Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma

Fig. 1

Study Flowchart. *One patient was excluded from the ChiCTR2000033946 trial because he did not meet the inclusion criteria, and three patients were excluded from the ChiCTR1800018137 trial because they did not meet the inclusion criteria or experienced rapid disease progression. ‡Three additional patients who received lymphodepletion were not dosed because of heart failure, severe liver function impairment, or severe infection. #One patient from both the ChiCTR1800018137 and ChiCTR2000033946 trials was excluded because of severe CRS and brain death

Back to article page